Appeals Court Overturns FTC Order On Settlements Of Drug Patent Disputes
The U.S. Court of Appeals for the 11th Circuit, based in Atlanta, ruled that Schering did not violate antitrust laws in patent litigation settlements involving its controlled-release potassium chloride supplement K-Dur 20.
The court reversed a 2003 finding by the FTC that drug makers Schering,...
Already a subscriber? Click here to login